Laparoscopic Enucleation of Frantz's Tumor of the Pancreas

• Sponsor: Tecnologico de Monterrey (Other)
• Overall Status: Completed
• CT.gov ID: NCT04728750
• Collaborator: (none)
• Enrollment: 1
• Location: 1
• Actual Duration (Months): 1.1
• Patients Per Site Per Month: 1

Study Details

Study Description

Brief Summary

The present study describes a 32-year-old female patient, in whom a preoperative imaging diagnosis confirmed a mass in the junction of the body and tail of the pancreas. Based on the anamnesis, on the preoperative diagnosis, and on the general status of the patient, the decision was made to performed laparoscopic enucleation of the pancreatic tumor. The operation and postoperative recovery passed without complications. A minimally invasive surgical approach should be applied whenever the dimensions and the localization of the tumor permits it, bearing in mind all the benefits and advantages that this surgical technique has to offer.

Condition or Disease	Intervention/Treatment	Phase
Solid Pseudopapillary Neoplasm of the Pancreas	Procedure: Enucleation of a tumor of the pancreas

Study Design

• Study Type: Observational
• Actual Enrollment: 1 participants
• Observational Model: Case-Only
• Time Perspective: Retrospective
• Official Title: Laparoscopic Enucleation of Frantz's Tumor of the Pancreas: Case Report and Literature Review
• Actual Study Start Date: Dec 1, 2020
• Actual Primary Completion Date: Jan 1, 2021
• Actual Study Completion Date: Jan 2, 2021

Outcome Measures

Primary Outcome Measures

1. Complete enucleation of a tumor in the pancreas [December 2020]

   Performance of a laparoscopic enucleation of a tumor in the pancreas, and compared it with a conventional approach

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 100 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Patients with benign tumor of the pancreas

• Patients with a size tumor of less than 3 cm on the pancreas

Exclusion Criteria:

• Patients with a size tumor greater than 3 cm on the pancreas

• Malignant tumors of the pancreas

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Escuela Nacional de Medicina, Tecnologico de Monterrey	Monterrey	Nuevo Leon	Mexico	76140

Sponsors and Collaborators

• Tecnologico de Monterrey

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Alejandro Ruiz Velasco Santacruz, Clinical Professor, Tecnologico de Monterrey
• ClinicalTrials.gov Identifier: NCT04728750
• Other Study ID Numbers: FT7831
• First Posted: Jan 28, 2021
• Last Update Posted: Jan 28, 2021
• Last Verified: Jan 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Pancreatic Neoplasms; Pancrelipase

Study Results

No Results Posted as of Jan 28, 2021